All filters
Videos
Update on Therapeutics Options- Roger Paredes, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Impact on Vaccine Efficacy- Ravindra Gupta, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
HBV - Treatment- Maria Buti, MD, FAASLD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Improving European Healthcare - Lessons Learned from the COVID-19 Pandemic - Dominique Costagliola, PhD
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
Integrating New HIV Treatments in the COVID-19 Era- Chloe Orkin, MBChB, FRCP, MD,
Presented at:
European Meeting on HIV & Hepatitis 2021
Videos
COVID-19 in People Living with HIV- Anna Maria Geretti, MD, PhD, FRCPath
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic
A. Chrysostomou
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Characterization of SARS-CoV-2 variants circulating in Central Italy by deep-sequencing of full-length S gene
M. Bellocchi
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
High sensitivity pool testing for SARS-CoV-2 RNA from throat wash and nasopharyngeal swabs
M. Dusek
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Significant SARS-CoV-2 RNA decay during remdesivir treatment in real life COVID-19 hospitalized patients
L. Piermatteo
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers
S. Marot
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Long-acting HIV capsid inhibitor effective as PrEP in a SHIV rhesus macaque model
E. Bekerman
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Prevalence of genotypic baseline risk factors of cabotegravir+rilpivirine failure among ARV-naïve patients
C. Charpentier
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
HIV-1 subtypes B, G and CRF02_AG transmission cluster in Migrants population followed in Portugal based on sequence data
V. Pimentel
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Low prevalence of archived M184V/I mutations in 3 HIV-1 suppressed, switch studies
R. Wang
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Kinetics of archived M184V mutation in HIV-DNA from highly experienced HIV-infected patients with sustained viral suppression
R. Palich
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
HIV-1 reverse transcriptase natural polymorphism V106I does not alter the susceptibility and the genetic barrier to resistance to Doravirine in vitro.
F. Giammarino
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Virological efficacy of switch to 3TC/DTG in a real life cohort of suppressed HIV-1 patients with or without past M184V – The LAMRES Study
M. Santoro
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Exploratory Analysis of Baseline Phenotypic and Genotypic Parameters in Relation to Antiviral Activity for Fostemsavir (FTR) in Heavily Treatment-Experienced (HTE) Patients in the Phase 3 BRIGHTE Study
A. Merritt
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Determinants of HIV-1 late presentation in patients followed in Europe
M. Miranda
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Exploration of the possible mechanisms leading to greater mortality in people with limited drug options (LDO)
A. Cozzi-Lepri
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021
Abstracts
Dynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG+3TC or ATV/r+3TC dual therapy
F. Dragoni
Reviews in Antiviral Therapy & Infectious Diseases 2, 2021
Presented at:
European Meeting on HIV & Hepatitis 2021